GSK Consumer: Bad news continues - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

GSK Consumer: Bad news continues

Apr 16, 2003

GlaxoSmithkline Consumer Healthcare Ltd. (SBCH) has posted a 38% dip in its 1QFY04 net profits. Though we do not have the company's detailed release on the results, as per the declared numbers, the company's gross sales has dipped by over 4% during the March quarter. The company has however, clarified that it has not lost market share in the malted beverage segment. With this, SBCH's poor showing continues.

(Rs m)1QFY031QFY04ChangeFY03YoY Change
Net Sales1,8551,817-2.0%7,525-9.9%
Other Income4139-4.2%146-59.7%
Operating Profit (EBDIT)460350-23.9%1,498-16.0%
Operating Profit Margin (%)24.8%19.2% 19.9% 
Interest 32-17.2%24-66.6%
Profit before Tax463295-36.3%1,364-29.7%
Extraordinary items0-15--61-
Profit after Tax/(Loss)294182-38.3%850-34.6%
Net profit margin (%)15.9%10.0% 11.3% 
No. of Shares 45.445.4 45.4 
Diluted Earnings per share*25.916.0 18.7 
P/E Ratio 14.4 12.3 

2002 was one of the worst years for the company wherein it reported a 9% dip in topline and nearly 35% dip in profits. Going by the March quarter results, 2003 has also started on a weak note. Though the topline dip is marginal and is a sign that the fall in revenues is getting arrested, it remains an area of concern. Operating margins for the company have dipped to 19.2%, almost a 5% fall in operating margins. This was mainly on account of higher advertising spending (10.5% of sales in 1QFY04 as compared to 9.0% last year).

A 14% hike in advertising revenues indicates the pressure on the company to maintain its growth. In 2002, the management had clarified that a lot of the de-growth in topline came as a consequence of an inventory correction. However, the pressure on topline continues. Being a single product focused company, this sort of degrowth in topline is very worrying, much like what has happened to Colgate. The stock has consequently, been hammered in the last one year.

Expenses as a % of sales1QFY031QFY04
Finished goods0.6%0.9%
Staff cost10.4%10.9%
Other exps21.7%22.0%
Patent and trademark0.7%1.3%
Def. Rev. exps.0.7%0.7%

At Rs 230, the stock trades at 14x annualised 1QFY04 earnings with market cap. to sales at 1.4x. Though the company's past growth track record is enthusing, we believe that it is moving towards a Colgate type fate unless it de-risks its product portfolio.

Equitymaster requests your view! Post a comment on "GSK Consumer: Bad news continues". Click here!


More Views on News

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

What Led to the Massive Surge in the Stock of Jubilant FoodWorks? (Views On News)

Aug 18, 2021

Jubilant FoodWorks hits new high, surges 35% in a month on growth prospects.

Zomato Delivers a Hot Listing. Did You Grab a Bite? (Views On News)

Jul 23, 2021

Zomato scripted history on Friday by becoming India's first unicorn to debut on the stock exchanges.

Jubilant FoodWorks Hits Record High on Strong Sales Recovery in June Quarter (Views On News)

Jul 22, 2021

Jubilant FoodWorks is back in the black, aided by higher revenues despite the second wave disrupting operations.

Varun Beverages Q1 Review: Net Profit Rises Two-Fold; Board Announces 1:2 Bonus Issue (Views On News)

May 4, 2021

Varun Beverages' two-fold jump in profit came on the back of strong volume growth and demand recovery.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Apr 15, 2020 (Close)


  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks